Search
Research
Enhancing Protection against Influenza and COVID-19 for pregnant women and medically at risk children: EPIC StudyPregnant women are 3 times more likely to die from COVID-19 and over 7 times more likely to be admitted to an intensive care unit with influenza compared to non-pregnant women.
News & Events
The Kids Researchers to explore NEC Artificial Intelligence technologies for new medical diagnostic toolsThe Kids has signed an MoU with leading technology developer NEC Australia to explore opportunities to apply NEC’s AI technologies in our medical research.
News & Events
Call for mandatory pregnancy health warning labelling on alcoholic beveragesPerth’s The Kids Research Institute Australia has welcomed the McGowan Government’s call today for the immediate implementation of mandatory pregnancy health warning labels.
News & Events
Action welcomed on Fetal Alcohol Spectrum DisordersThe Telethon Kids Institute has welcomed the expansion of clinical services for young people with Fetal Alcohol Spectrum Disorders (FASD).
Research
Developing sensitive endpoints for respiratory disease progression in children with neuromuscular diseaseWe hope that through earlier diagnosis and treatment of muscle weakness during sleep, we can prevent future lung failure in children with neuromuscular disorders.
Research
KINDEE: Kids INfections and Day care’s Effects on the lungs in those born EarlyOver the last 40 years medical advances in the care of newborn babies has resulted in more children surviving very early “preterm” birth than ever before.
News & Events
Research enriching the lives of girls with Rett syndromeA program developed by The Kids Research Institute Australia researcher Dr Jenny Downs has led to dramatic improvements in the functioning of Chinese children with Rett syndrome, and could change the world.
Research
Wet CoughA wet cough in a child for more than four weeks could indicate infection in the lungs. The wet cough is caused by mucus in the airway. The mucus becomes infected with bacteria and causes airway inflammation that can progress to permanent lung damage known as bronchiectasis.
Research
Estimating the impact of Western Australia's first respiratory syncytial virus immunisation program for all infants: A mathematical modelling studyThe Australian Therapeutic Goods Administration approved the use of nirsevimab, a long-acting monoclonal antibody for the prevention of Respiratory Syncytial Virus (RSV), in November 2023. Western Australia (WA) implemented a combination of nirsevimab administration strategies designed to protect all infants starting in April 2024, before the epidemic season. We developed a dynamic transmission model to predict the impact of WA's RSV immunisation program on infant hospitalisations.
Research
Haemophilus influenzae remains the predominant otitis media pathogen in Australian children undergoing ventilation tube insertion in the PCV13 eraUnderstanding patterns of bacterial carriage and otitis media (OM) microbiology is crucial for assessing vaccine impact and informing policy. The microbiology of OM can vary with geography, time, and interventions like pneumococcal conjugate vaccines (PCVs). We evaluated the microbiology of nasopharyngeal and middle ear effusions in children living in Western Australia, 11 years following the introduction of PCV13.